PHATHOM PHARMACEUTICALS, INC.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2018 | $2.2M | $902.0K | $879.0K |
| Sep 2019 | $232.2M | $79.7M | $74.5M |
| Dec 2019 | $29.2M | $257.2M | $243.8M |
| Mar 2020 | $55.2M | $263.9M | $256.7M |
| Jun 2020 | $64.0M | $252.4M | $247.3M |
| Sep 2020 | $74.5M | $230.9M | $226.4M |
| Dec 2020 | $100.8M | $295.1M | $287.5M |
| Mar 2021 | $82.0M | $246.4M | $238.0M |
| Jun 2021 | $82.5M | $214.6M | $209.7M |
| Sep 2021 | $124.9M | $228.4M | $224.6M |
| Dec 2021 | $117.3M | $189.4M | $183.3M |
| Mar 2022 | $111.0M | $149.0M | $138.1M |
| Jun 2022 | $220.5M | $213.5M | $207.4M |
| Sep 2022 | $228.4M | $201.9M | $196.8M |
| Dec 2022 | $239.6M | $164.8M | $155.4M |
| Mar 2023 | $234.2M | $144.0M | $129.6M |
| Jun 2023 | $247.4M | $265.0M | $248.8M |
| Sep 2023 | $254.8M | $237.0M | $213.7M |
| Dec 2023 | $486.6M | $413.8M | $381.4M |
| Mar 2024 | $505.0M | $356.5M | $322.2M |
| Jun 2024 | $553.2M | $319.4M | $276.2M |
| Sep 2024 | $574.2M | $387.0M | $334.7M |
| Dec 2024 | $631.9M | $378.3M | $297.3M |
| Mar 2025 | $632.6M | $294.2M | $212.3M |
| Jun 2025 | $656.1M | $250.2M | $149.6M |
| Sep 2025 | $662.8M | $240.3M | $135.2M |
| Dec 2025 | $697.3M | $259.1M | $130.0M |
| Mar 2026 | $642.1M | $305.1M | $180.9M |
| Jun 2026 | $671.3M | $327.1M | $182.5M |